Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05397704 · ClinicalTrials.gov registry record · NA
Brain Oximeter Calibration and Validation Study
A NA study of Brain Injuries, Traumatic, sponsored by Cyban Pty.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT05397704: Completed NA study of Brain Injuries, Traumatic, sponsored by Cyban Pty.
NCT05397704 is a NA study of Brain Injuries, Traumatic that has completed, run by Cyban Pty. The registered enrollment target is 21 participants, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05397704, a NA study of Brain Injuries, Traumatic, has completed, sponsored by Cyban Pty.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to calibrate and to validate the accuracy of the oximeter with an estimate of brain oxygen levels assessed by measuring arterial and internal jugular vein blood oxygen saturations.
Primary Outcome
Bland Altman analysis
Conditions Studied
Interventions
- DEVICE brain pulse oximeter
Study Locations (1)
North Carolina
- Duke Hospital Human Pharmacology & Physiology Lab - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-10-10 |
| Est. Completion | 2022-11-15 |
| Phase | NA |
What the finished NCT05397704 record still lists
NCT05397704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 255-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 1 intervention - of which brain pulse oximeter is the first listed.
NCT05397704 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05397704 about?
NCT05397704 is a clinical study titled "Brain Oximeter Calibration and Validation Study". The purpose of the study is to calibrate and to validate the accuracy of the oximeter with an estimate of brain oxygen levels assessed by measuring arterial and internal jugular vein blood oxygen saturations.
What is the current status of trial NCT05397704?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-10-10. Estimated completion is 2022-11-15.
What conditions does trial NCT05397704 study?
This clinical trial studies the following conditions: Brain Injuries, Traumatic.
What interventions are being tested in trial NCT05397704?
The interventions under investigation include: brain pulse oximeter (DEVICE).
Who is sponsoring clinical trial NCT05397704?
This trial is sponsored by Cyban Pty, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05397704 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Injuries, Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05397704's enrollment target sits among peer trials
21 20th of 21 higher than 2 of 21 other Brain Injuries, Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Injuries, Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Morning Bright Light to Improve Sleep Quality in Veterans
RECRUITING · NA
-
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
RECRUITING · NA
-
Brain Oxygen Optimization in Severe TBI, Phase 3
RECRUITING · NA
-
NEUROBALANCE Training to Improve Postural Control in Individuals With Traumatic Brain Injury
RECRUITING · NA
-
Brain Injury Education and Outpatient Navigation-1stBIEN
RECRUITING · NA
-
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI